The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Structure Therapeutics Inc ADR (NASDAQ: GPCR) closed at $25.33 in the last session, down -8.04% from day before closing price of $27.55. In other words, the price has decreased by -$8.04 from its previous closing price. On the day, 1.13 million shares were traded.
Ratios:
We take a closer look at GPCR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 24.74 and its Current Ratio is at 24.74. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on May 02, 2025, initiated with a Buy rating and assigned the stock a target price of $60.
On January 08, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $50.Stifel initiated its Buy rating on January 08, 2025, with a $50 target price.
Stock Price History:
Over the past 52 weeks, GPCR has reached a high of $62.74, while it has fallen to a 52-week low of $13.22. The 50-Day Moving Average of the stock is 20.73%, while the 200-Day Moving Average is calculated to be -18.40%.
Shares Statistics:
A total of 57.29M shares are outstanding, with a floating share count of 54.47M. Insiders hold about 4.91% of the company’s shares, while institutions hold 102.88% stake in the company.
